NVST vs OPCH
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
NVST presents a complex profile with a stable Piotroski F-Score of 4/9 and a significant valuation gap, as the current price of $25.94 far exceeds the Graham Number ($10.93) and Intrinsic Value ($8.26). While the company shows strong short-term price momentum (+61.3% 1Y) and a highly attractive Forward P/E of 16.64, its trailing P/E of 92.64 and razor-thin profit margin of 1.73% indicate a precarious transition period. The bullish analyst consensus is countered by bearish insider sentiment and a 0/100 technical trend, suggesting the market is pricing in a recovery that has not yet fully materialized in the fundamentals.
OPCH exhibits strong operational health with a Piotroski F-Score of 7/9, indicating a robust financial foundation. However, there is a severe disconnect between the current market price ($26.87) and deterministic value metrics, with the Graham Number ($15.54) and Intrinsic Value ($11.37) suggesting significant overvaluation. While analysts remain aggressively bullish with a $40.09 target, this is contradicted by bearish insider selling and a 0/100 technical trend. The stock appears to be a high-quality business trading at a speculative premium.
Compare Another Pair
Related Comparisons
NVST vs OPCH: Head-to-Head Comparison
This page compares Envista Holdings Corporation (NVST) and Option Care Health, Inc. (OPCH) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.